Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 187

    1.

    A case control study of age related macular degeneration and use of statins.

    Smeeth L, Cook C, Chakravarthy U, Hubbard R, Fletcher AE.

    Br J Ophthalmol. 2005 Sep;89(9):1171-5.PMID: 16113375 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    A case-control study of drug risk factors for age-related macular degeneration.

    Douglas IJ, Cook C, Chakravarthy U, Hubbard R, Fletcher AE, Smeeth L.

    Ophthalmology. 2007 Jun;114(6):1164-9.PMID: 17544775 [PubMed - indexed for MEDLINE]Related articles

    3.

    Use of statins and the risk of Parkinson's disease: a retrospective case-control study in the UK.

    Becker C, Jick SS, Meier CR.

    Drug Saf. 2008;31(5):399-407.PMID: 18422380 [PubMed - indexed for MEDLINE]Related articles

    4.

    Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degeneration.

    Wilson HL, Schwartz DM, Bhatt HR, McCulloch CE, Duncan JL.

    Am J Ophthalmol. 2004 Apr;137(4):615-24.PMID: 15059698 [PubMed - indexed for MEDLINE]Related articles

    5.

    [Use of statins as a form of protection against age-related macular degeneration (AMD)]

    Drobek-Słowik M, Karczewicz D, Safranow K, Jakubowska K, Chlubek D.

    Klin Oczna. 2008;110(1-3):50-4. Polish. PMID: 18669084 [PubMed - indexed for MEDLINE]Related articles

    6.

    Statins do not decrease the risk for wet age-related macular degeneration.

    Kaiserman N, Vinker S, Kaiserman I.

    Curr Eye Res. 2009 Apr;34(4):304-10.PMID: 19373579 [PubMed - indexed for MEDLINE]Related articles

    7.

    3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors and the presence of age-related macular degeneration in the Cardiovascular Health Study.

    McGwin G Jr, Modjarrad K, Hall TA, Xie A, Owsley C.

    Arch Ophthalmol. 2006 Jan;124(1):33-7.PMID: 16401782 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Cataract and the use of statins: a case-control study.

    Smeeth L, Hubbard R, Fletcher AE.

    QJM. 2003 May;96(5):337-43.PMID: 12702782 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Use of statins and risk of fractures.

    van Staa TP, Wegman S, de Vries F, Leufkens B, Cooper C.

    JAMA. 2001 Apr 11;285(14):1850-5. Erratum in: JAMA 2001 Aug 8;286(6):674. PMID: 11308398 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Statin use and the five-year incidence and progression of age-related macular degeneration.

    Klein R, Knudtson MD, Klein BE.

    Am J Ophthalmol. 2007 Jul;144(1):1-6. Epub 2007 May 2.PMID: 17475196 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Moderate wine consumption is associated with decreased odds of developing age-related macular degeneration in NHANES-1.

    Obisesan TO, Hirsch R, Kosoko O, Carlson L, Parrott M.

    J Am Geriatr Soc. 1998 Jan;46(1):1-7.PMID: 9434658 [PubMed - indexed for MEDLINE]Related articles

    12.

    Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.

    Harley CR, Gandhi S, Blasetto J, Heien H, Sasane R, Nelson SP.

    Am J Geriatr Pharmacother. 2007 Sep;5(3):185-94.PMID: 17996658 [PubMed - indexed for MEDLINE]Related articles

    13.

    Use of statins and angiotensin converting enzyme inhibitors (ACE-Is) and the risk of age-related macular degeneration: nested case-control study.

    Etminan M, Brophy JM, Maberley D.

    Curr Drug Saf. 2008 Jan;3(1):24-6.PMID: 18690977 [PubMed - indexed for MEDLINE]Related articles

    14.

    Extremely discordant sib-pair study design to determine risk factors for neovascular age-related macular degeneration.

    DeAngelis MM, Lane AM, Shah CP, Ott J, Dryja TP, Miller JW.

    Arch Ophthalmol. 2004 Apr;122(4):575-80.PMID: 15078676 [PubMed - indexed for MEDLINE]Related articles

    15.

    Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation.

    Khan JC, Thurlby DA, Shahid H, Clayton DG, Yates JR, Bradley M, Moore AT, Bird AC; Genetic Factors in AMD Study.

    Br J Ophthalmol. 2006 Jan;90(1):75-80.PMID: 16361672 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Neovascular age-related macular degeneration risk based on CFH, LOC387715/HTRA1, and smoking.

    Hughes AE, Orr N, Patterson C, Esfandiary H, Hogg R, McConnell V, Silvestri G, Chakravarthy U.

    PLoS Med. 2007 Dec;4(12):e355.PMID: 18162041 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Risk of cataract in patients treated with statins.

    Schlienger RG, Haefeli WE, Jick H, Meier CR.

    Arch Intern Med. 2001 Sep 10;161(16):2021-6.PMID: 11525705 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Statins and the risk of pneumonia: a population-based, nested case-control study.

    Schlienger RG, Fedson DS, Jick SS, Jick H, Meier CR.

    Pharmacotherapy. 2007 Mar;27(3):325-32.PMID: 17316144 [PubMed - indexed for MEDLINE]Related articles

    19.

    CFH gene variant, Y402H, and smoking, body mass index, environmental associations with advanced age-related macular degeneration.

    Seddon JM, George S, Rosner B, Klein ML.

    Hum Hered. 2006;61(3):157-65. Epub 2006 Jun 30.PMID: 16816528 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Statins reduce the risk of pancreatic cancer in humans: a case-control study of half a million veterans.

    Khurana V, Sheth A, Caldito G, Barkin JS.

    Pancreas. 2007 Mar;34(2):260-5.PMID: 17312467 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data